Rnai-based screening identifies kinases interfering with dioxin-mediated up-regulation of CYP1A1 activity

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Gilot, David ^a,c   Le Meur, Nolwenn ^a   Giudicelli, Fanny ^a   Le Vée, Marc ^a   Lagadic Gossmann, Dominique ^a   Théret, Nathalie ^a   Fardel, Olivier ^a,b  

^a UNIVERSITÉ DE RENNES 1   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ADENYLATE KINASE 3; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CHAPERONIN CONTAINING TCP1 SUBUNIT 2; COENZYME A SYNTHETASE; CYTOCHROME P450 1A1; ETHOXYRESORUFIN DEETHYLASE; HOMEDOMAIN INTERACTING PROTEIN KINASE 1; INOSITOL POLYPHOSPHATE MULTIKINASE; INOSITOL TRISPHOSPHATE 3 KINASE A; IP3 KINASE A; LEMUR TYROSINE KINASE 2; LEMUR TYROSINE KINASE 3; MAGUK P55 SUBFAMILY MEMBER 6 KINASE; MYOSIN IIIA; NIK RELATED KINASE; PHOSPHOINOSITIDE 3 KINASE CLASS 2 GAMMA POLYPEPTIDE; PHOSPHOMEVALONATE KINASE; PIM 2 ONCOGENE; PREGNANCY UPREGULATED NON UBIQUITOUSLY EXPRESSED CAM KINASE; PROTEIN KINASE; PRP4 PRE MIRNA PROCESSING FACTOR 4 HOMOLOG B; SH3 BINDING DOMAIN KINASE 1; SMALL INTERFERING RNA; SNF1 LIKE KINASE 2; SPHINGOSINE KINASE 1; TRIBBLES HOMOLOG 2; UNCLASSIFIED DRUG; URIDINE CYTIDINE KINASE 1; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE I; INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE; INOSITOL TRISPHOSPHATE 3 KINASE; PHOSPHOTHREONINE; PHOSPHOTRANSFERASE; PNCK PROTEIN, HUMAN;

ARTICLE; CELL CYCLE; CELL DENSITY; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE LIBRARY; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; PREGNANCY; PROTEIN BINDING; PROTEIN EXPRESSION; RNA INTERFERENCE; UPREGULATION; DRUG EFFECT; GENETICS; METABOLISM; PHOSPHORYLATION; REPRODUCIBILITY; TUMOR CELL LINE;

CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 1; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYTOCHROME P-450 CYP1A1; HUMANS; PHOSPHORYLATION; PHOSPHOTHREONINE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN KINASES; REPRODUCIBILITY OF RESULTS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TETRACHLORODIBENZODIOXIN; UP-REGULATION;

EID: 79953182317     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018261     Document Type: Article

References (42)

1. Barouki R, Coumoul X, Fernandez-Salguero PM, (2007) The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett 581: 3608-3615.
2. Okey AB, Riddick DS, Harper PA, (1994) The Ah receptor: mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Toxicol Lett 70: 1-22.
3. Schwarz M, Appel KE, (2005) Carcinogenic risks of dioxin: mechanistic considerations. Regul Toxicol Pharmacol 43: 19-34.
4. Fernandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM, Gonzalez FJ, (1996) Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol 140: 173-179.
5. McMillan BJ, Bradfield CA, (2007) The aryl hydrocarbon receptor sans xenobiotics: endogenous function in genetic model systems. Mol Pharmacol 72: 487-498.
6. Swanson HI, (2002) DNA binding and protein interactions of the AHR/ARNT heterodimer that facilitate gene activation. Chem Biol Interact 141: 63-76.
7. Tijet N, Boutros PC, Moffat ID, Okey AB, Tuomisto J, et al. (2006) Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol Pharmacol 69: 140-153.
8. Oesch-Bartlomowicz B, Oesch F, (2009) Role of cAMP in mediating AHR signaling. Biochem Pharmacol 77: 627-641.
9. N'Diaye M, Le Ferrec E, Lagadic-Gossmann D, Corre S, Gilot D, et al. (2006) Aryl hydrocarbon receptor- and calcium-dependent induction of the chemokine CCL1 by the environmental contaminant benzo[a]pyrene. J Biol Chem 281: 19906-19915.
10. Matsumura F, (2009) The significance of the nongenomic pathway in mediating inflammatory signaling of the dioxin-activated Ah receptor to cause toxic effects. Biochem Pharmacol 77: 608-626.
11. Puga A, Ma C, Marlowe JL, (2009) The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem Pharmacol 77: 713-722.
12. Hunter T, (2009) Tyrosine phosphorylation: thirty years and counting. Curr Opin Cell Biol 21: 140-146.
13. Gilot D, Giudicelli F, Lagadic-Gossmann D, Fardel O, (2010) Akti-1/2; an allosteric inhibitor of Akt 1 and 2; efficiently inhibits CaMKIalpha activity and aryl hydrocarbon receptor pathway. Chem Biol Interact.
14. Braeuning A, Buchmann A, (2009) The glycogen synthase kinase inhibitor 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763) is a partial agonist of the aryl hydrocarbon receptor. Drug Metab Dispos 37: 1576-1580.
15. Bachleda P, Dvorak Z, (2008) Pharmacological inhibitors of JNK and ERK kinases SP600125 and U0126 are not appropriate tools for studies of drug metabolism because they activate aryl hydrocarbon receptor. Gen Physiol Biophys 27: 143-145.
16. Monteiro P, Gilot D, Langouet S, Fardel O, (2008) Activation of the aryl hydrocarbon receptor by the calcium/calmodulin-dependent protein kinase kinase inhibitor 7-oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic acid (STO-609). Drug Metab Dispos 36: 2556-2563.
17. Han EH, Kim HG, Im JH, Jeong TC, Jeong HG, (2009) Up-regulation of CYP1A1 by rutaecarpine is dependent on aryl hydrocarbon receptor and calcium. Toxicology 266: 38-47.
18. Lin CH, Juan SH, Wang CY, Sun YY, Chou CM, et al. (2008) Neuronal activity enhances aryl hydrocarbon receptor-mediated gene expression and dioxin neurotoxicity in cortical neurons. J Neurochem 104: 1415-1429.
19. Monteiro P, Gilot D, Le Ferrec E, Rauch C, Lagadic-Gossmann D, et al. (2008) Dioxin-mediated up-regulation of aryl hydrocarbon receptor target genes is dependent on the calcium/calmodulin/CaMKIalpha pathway. Mol Pharmacol 73: 769-777.
20. Rodriguez-Mora OG, LaHair MM, McCubrey JA, Franklin RA, (2005) Calcium/calmodulin-dependent kinase I and calcium/calmodulin-dependent kinase kinase participate in the control of cell cycle progression in MCF-7 human breast cancer cells. Cancer Res 65: 5408-5416.
21. Zayzafoon M, (2006) Calcium/calmodulin signaling controls osteoblast growth and differentiation. J Cell Biochem 97: 56-70.
22. Enan E, Matsumura F, (1996) Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway. Biochem Pharmacol 52: 1599-1612.
23. Barhoover MA, Hall JM, Greenlee WF, Thomas RS, (2010) Aryl hydrocarbon receptor regulates cell cycle progression in human breast cancer cells via a functional interaction with cyclin-dependent kinase 4. Mol Pharmacol 77: 195-201.
24. Tan Z, Huang M, Puga A, Xia Y, (2004) A critical role for MAP kinases in the control of Ah receptor complex activity. Toxicol Sci 82: 80-87.
25. Pelz O, Gilsdorf M, Boutros M, (2010) web cellHTS2: a web-application for the analysis of high-throughput screening data. BMC Bioinformatics 11: 185.
26. Mullenders J, Bernards R, (2009) Loss-of-function genetic screens as a tool to improve the diagnosis and treatment of cancer. Oncogene 28: 4409-4420.
27. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S, (2002) The protein kinase complement of the human genome. Science 298: 1912-1934.
28. Giet R, Petretti C, Prigent C, (2005) Aurora kinases, aneuploidy and cancer, a coincidence or a real link? Trends Cell Biol 15: 241-250.
29. Piva R, Chiarle R, Manazza AD, Taulli R, Simmons W, et al. (2006) Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas. Blood 107: 689-697.
30. Mahajan S, Ghosh S, Sudbeck EA, Zheng Y, Downs S, et al. (1999) Rational design and synthesis of a novel anti-leukemic agent targeting Bruton's tyrosine kinase (BTK), LFM-A13 [alpha-cyano-beta-hydroxy-beta-methyl-N-(2, 5-dibromophenyl)propenamide]. J Biol Chem 274: 9587-9599.
31. Howard S, Berdini V, Boulstridge JA, Carr MG, Cross DM, et al. (2009) Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activity. J Med Chem 52: 379-388.
32. Echeverri CJ, Beachy PA, Baum B, Boutros M, Buchholz F, et al. (2006) Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat Methods 3: 777-779.
33. Archuleta MM, Schieven GL, Ledbetter JA, Deanin GG, Burchiel SW, (1993) 7,12-Dimethylbenz[a]anthracene activates protein-tyrosine kinases Fyn and Lck in the HPB-ALL human T-cell line and increases tyrosine phosphorylation of phospholipase C-gamma 1, formation of inositol 1,4,5-trisphosphate, and mobilization of intracellular calcium. Proc Natl Acad Sci U S A 90: 6105-6109.
34. Davila DR, Lane JL, Lauer FT, Burchiel SW, (1999) Protein tyrosine kinase activation by polycyclic aromatic hydrocarbons in human HPB-ALL T cells. J Toxicol Environ Health A 56: 249-261.
35. Naito Y, Watanabe Y, Yokokura H, Sugita R, Nishio M, et al. (1997) Isoform-specific activation and structural diversity of calmodulin kinase I. J Biol Chem 272: 32704-32708.
36. Condon JC, Pezzi V, Drummond BM, Yin S, Rainey WE, (2002) Calmodulin-dependent kinase I regulates adrenal cell expression of aldosterone synthase. Endocrinology 143: 3651-3657.
37. Chen S, Operana T, Bonzo J, Nguyen N, Tukey RH, (2005) ERK kinase inhibition stabilizes the aryl hydrocarbon receptor: implications for transcriptional activation and protein degradation. J Biol Chem 280: 4350-4359.
38. Wang Y, Liao M, Hoe N, Acharya P, Deng C, et al. (2009) A role for protein phosphorylation in cytochrome P450 3A4 ubiquitin-dependent proteasomal degradation. J Biol Chem 284: 5671-5684.
39. Oesch-Bartlomowicz B, Oesch F, (2005) Phosphorylation of cytochromes P450: first discovery of a posttranslational modification of a drug-metabolizing enzyme. Biochem Biophys Res Commun 338: 446-449.
40. Gardner HP, Rajan JV, Ha SI, Copeland NG, Gilbert DJ, et al. (2000) Cloning, characterization, and chromosomal localization of Pnck, a Ca(2+)/calmodulin-dependent protein kinase. Genomics 63: 279-288.
41. Xia HJ, Yang G, (2005) Inositol 1,4,5-trisphosphate 3-kinases: functions and regulations. Cell Res 15: 83-91.
42. Micheau O, Solary E, Hammann A, Martin F, Dimanche-Boitrel MT, (1997) Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity. J Natl Cancer Inst 89: 783-789.